Skip to main content

Amgen Repatha revenue

  • AMGN · Nasdaq
  • Biotechnology
  • S&P 500
$465.67−0.30%Close 13 Nov 2026 · Market value $253.3B

Repatha revenue at Amgen came to $1.1B for the quarter to 30 Sep 2026, up 36.6% from a year earlier.

As Amgen reported it in its earnings release and quarterly or annual report, compiled and checked by AapWire. Latest figure filed 4 Nov 2026.

By quarter

$417.0MDec 2023$517.0MMar 2024$532.0MJun 2024$567.0MSep 2024$606.0MDec 2024$656.0MMar 2025$696.0MJun 2025$794.0MSep 2025$870.0MDec 2025$876.0MMar 2026$953.0MJun 2026$1.1BSep 2026
Amgen Repatha revenue, every reported period
Period endingRepatha revenueChange on a yearFiled
30 Sep 2026$1.1Bup 36.6%4 Nov 2026
30 Jun 2026$953.0Mup 36.9%5 Aug 2026
31 Mar 2026$876.0Mup 33.5%1 May 2026
31 Dec 2025$870.0Mup 43.6%13 Feb 2026
30 Sep 2025$794.0Mup 40.0%5 Nov 2025
30 Jun 2025$696.0Mup 30.8%6 Aug 2025
31 Mar 2025$656.0Mup 26.9%2 May 2025
31 Dec 2024$606.0Mup 45.3%14 Feb 2025
30 Sep 2024$567.0Mup 39.7%31 Oct 2024
30 Jun 2024$532.0Mup 25.5%7 Aug 2024
31 Mar 2024$517.0Mup 33.2%3 May 2024
31 Dec 2023$417.0Mup 25.2%14 Feb 2024
30 Sep 2023$406.0Mup 31.4%31 Oct 2023
30 Jun 2023$424.0Mup 30.5%4 Aug 2023
31 Mar 2023$388.0Mup 17.9%28 Apr 2023
31 Dec 2022$333.0Mup 22.0%9 Feb 2023
30 Sep 2022$309.0Mup 13.6%4 Nov 2022
30 Jun 2022$325.0Mup 13.6%5 Aug 2022
31 Mar 2022$329.0Mup 15.0%28 Apr 2022
31 Dec 2021$273.0Mup 7.9%16 Feb 2022
30 Sep 2021$272.0Mup 32.7%3 Nov 2021
30 Jun 2021$286.0Mup 43.0%4 Aug 2021
31 Mar 2021$286.0Mup 24.9%28 Apr 2021
31 Dec 2020$253.0Mup 26.5%9 Feb 2021
30 Sep 2020$205.0Mup 22.0%29 Oct 2020
30 Jun 2020$200.0Mup 31.6%29 Jul 2020
31 Mar 2020$229.0Mup 62.4%1 May 2020
31 Dec 2019$200.0M—12 Feb 2020
30 Sep 2019$168.0M—30 Oct 2019
30 Jun 2019$152.0M—31 Jul 2019
31 Mar 2019$141.0M—1 May 2019

Definition

Revenue from this part of the business, as the company names and reports it in its results. Each figure is read from the table or sentence the company printed and kept with its scale and decimals; see data and methodology.

Other operating KPIs of Amgen: Product sales · EVENITY revenue · Prolia revenue · ENBREL revenue · TEZSPIRE revenue · TEPEZZA revenue · BLINCYTO revenue · Otezla revenue · Nplate revenue · UPLIZNA revenue · KRYSTEXXA revenue · IMDELLTRA/IMDYLLTRA revenue · Vectibix revenue · KYPROLIS revenue · Aranesp revenue · XGEVA revenue · United States revenue · ROW revenue · financial statements

Every KPI and segment of AMGN, in the terminal.

Ten years of operating figures, segments, guidance against results, charts and alerts on each new release.